Lexeo Therapeutics, Inc. (LXEO) Change in Account Payables (2022 - 2023)
Lexeo Therapeutics' Change in Account Payables history spans 2 years, with the latest figure at $394000.0 for Q4 2023.
- For Q4 2023, Change in Account Payables rose 132.27% year-over-year to $394000.0; the TTM value through Dec 2023 reached -$180000.0, changed N/A, while the annual FY2024 figure was $2.4 million, 1421.11% up from the prior year.
- Change in Account Payables for Q4 2023 was $394000.0 at Lexeo Therapeutics, up from $290000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.0 million in Q1 2023 and bottomed at -$1.9 million in Q2 2023.